ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
103,576.32
-0.53%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Terns Pharmaceuticals Inc (TERN) 시세

Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc (TERN)

Tern Plc
4.43
-0.07
(-1.56%)
마감 18 1월 6:00AM
15분 지연
4.45
0.02
(0.45%)
시간외 거래: 8:56AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
4.45
매수가
4.41
매도가
4.51
거래량
1,481,423
4.3802 일간 변동폭 4.615
4.32 52주 범위 11.40
market_cap
377.978M
전일 종가
4.50
개장가
4.52
최근 거래 시간
1
@
4.42
마지막 거래 시간
재정 규모
US$ 6,671,834
VWAP
4.5037
평균 볼륨(3m)
1,670,321
발행 주식
84,938,855
배당수익률
-
주가수익률
-4.17
주당순이익(EPS)
-1.06
매출
-
순이익
-90.21M

Terns Pharmaceuticals Inc 정보

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.ternspharma.com
본부
Wilmington, Delaware, USA
설립됨
-
Terns Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker TERN. The last closing price for Terns Pharmaceuticals was US$4.50. Over the last year, Terns Pharmaceuticals shares have traded in a share price range of US$ 4.32 to US$ 11.40.

Terns Pharmaceuticals currently has 84,938,855 shares in issue. The market capitalisation of Terns Pharmaceuticals is US$382.22 million. Terns Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.17.

TERN 최신 뉴스

추가 뉴스

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

FOSTER CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

09 1월 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

07 1월 2025
Edgar (US Regulatory)

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

03 1월 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

17 12월 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 12월 2024
Edgar (US Regulatory)

Form 8-K - Current report

03 12월 2024
Edgar (US Regulatory)

Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia

Compelling molecular responses starting at lowest dose level in heavily pre-treated patients with high baseline BCR-ABL transcript levels Encouraging safety profile with no dose limiting...

03 12월 2024
GlobeNewswire Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio...

03 12월 2024
GlobeNewswire Inc.

Form 8-K - Current report

19 11월 2024
Edgar (US Regulatory)

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

FOSTER CITY, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...

19 11월 2024
GlobeNewswire Inc.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.65-12.74509803925.15.144.4216663404.71049054CS
4-1.45-24.57627118645.96.134.4216999045.42124598CS
12-2.32-34.26883308716.777.62994.4216703216.17029008CS
26-4.3-49.14285714298.7511.44.4217429447.67557963CS
52-1.24-21.79261862925.6911.44.3213767177.34352232CS
156-1.3-22.60869565225.7514.04351.457255877.28593408CS
260-12.5-73.746312684416.9528.361.455746577.65638355CS

TERN - Frequently Asked Questions (FAQ)

What is the current Terns Pharmaceuticals share price?
The current share price of Terns Pharmaceuticals is US$ 4.45
How many Terns Pharmaceuticals shares are in issue?
Terns Pharmaceuticals has 84,938,855 shares in issue
What is the market cap of Terns Pharmaceuticals?
The market capitalisation of Terns Pharmaceuticals is USD 382.22M
What is the 1 year trading range for Terns Pharmaceuticals share price?
Terns Pharmaceuticals has traded in the range of US$ 4.32 to US$ 11.40 during the past year
What is the PE ratio of Terns Pharmaceuticals?
The price to earnings ratio of Terns Pharmaceuticals is -4.17
What is the reporting currency for Terns Pharmaceuticals?
Terns Pharmaceuticals reports financial results in USD
What is the latest annual profit for Terns Pharmaceuticals?
The latest annual profit of Terns Pharmaceuticals is USD -90.21M
What is the registered address of Terns Pharmaceuticals?
The registered address for Terns Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Terns Pharmaceuticals website address?
The website address for Terns Pharmaceuticals is www.ternspharma.com
Which industry sector does Terns Pharmaceuticals operate in?
Terns Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

토론

전체 피드 보기
georgie18 georgie18 4 분 전
BITF...$1.68...🥳...Scaling in on the Bollie Squeeze... https://schrts.co/BChrDIcy ...
BITF
georgie18 georgie18 5 분 전
WULF...$6.40...🥳...Scaling in on Bullish Kicking Reversal Pattern...Bollies starting to Squeeze here... https://schrts.co/bPFSagwd ...
WULF
georgie18 georgie18 5 분 전
WULF...$6.40...🥳...Scaling in on Bullish Kicking Reversal Pattern...Bollies starting to Squeeze here... https://schrts.co/bPFSagwd ...
StayHumble StayHumble 6 분 전
w0w💹MAJOR UPDATE💹$83 Possible PerSEC regulations💹 wow! https://ih.advfn.com/stock-market/USOTC/ubiquitech-software-pk-UBQU/historical


https://x.com/CorporateUbqu/status/1767983893544566905?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E17679838935
UBQU
georgie18 georgie18 7 분 전
WULF...$6.40...🥳...Scaling in on Bullish Kicking Reversal Pattern...Bollies starting to Squeeze here... https://schrts.co/bPFSagwd ...
wagner wagner 7 분 전
Ok

2025 

Financing is more than imminent 

Otherwise 

Please Mark sale

NB
georgie18 georgie18 11 분 전
BITF...$1.68...🥳...Scaling in on the Bollie Squeeze... https://schrts.co/BChrDIcy ...
BITF
Hi_Lo Hi_Lo 14 분 전
The SEC doesn't care about OTC Markets alternate reporting standards.

HQGE must be registered with the SEC through a Form S-4 (or Form 10) which HQGE can't do because it had its registration with the SEC terminated and still has missing financials from all of 2022, 2023 and the 2024 q
HQGE
Ranb2khz Ranb2khz 16 분 전
Jesus Does – We the Kingdom (Lyrics)

[yt]qiT8vUM1dpI[/yt]

https://www.youtube.com/watch?v=qiT8vUM1dpI






•
JAB65 JAB65 16 분 전
This as well!

But why not enjoy the best of both worlds? Make BigBux on the news like the TELL bump and hold a percentage for the long haul. Pretty simple strategy.

Oh and also less I forget, don't let the door hit you on the way out!

$TGLO
TGLO
StayHumble StayHumble 16 분 전
idiot, are10ks💹8ks💹ALJs m00t? SEC FAV0URS $DBMM💹
Meaning the ruling? +1

Source: https://www.sec.gov/alj/aljdec/2019/id1389cff.pdf
No available sanction appropriate|Thus Proceeding Dismissed.
-------------------------------V. ORDE
DBMM
KIPK KIPK 17 분 전
Totally Agree!!!
SRMX
chrismiss_everyday chrismiss_everyday 17 분 전
https://www.linkedin.com/feed/update/urn:li:activity:7286268299393290240/
AVXL
Hi_Lo Hi_Lo 17 분 전
HQGE had its registration statement terminated all the way back in 2012 by the SEC and they were never able to renew it.

https://www.otcmarkets.com/filing/html?id=8880161&guid=q0O-kHuCxwIqJth

No financials since 11/23/2021 which means HQGE is delinquent with the SEC.
HQGE
RiseandShine RiseandShine 18 분 전
The Louisiana location is a 900,000 sq Cotton Mill a previous Froot of the Loom plant at:
1 King Timahoe Dr, Vidalia, LA 71373

On July 19, 2018, Vidalia Mills signed closing documents on its purchase of the old Fruit of the Loom plant from the Town of Vidalia, including the 900
TWOH
jeunke22 jeunke22 20 분 전
Sorry. Appeared in my feed today, Didn’t check date.
NB
TrendTrade2016 TrendTrade2016 20 분 전
THE BEST MONEY MANAGERS ARE 50% CASH AND LIMITING THEIR EXPOSURE TO STOCKS
Hi_Lo Hi_Lo 21 분 전
Lionsgate has never verified and/or confirmed the "deal." with SAPX.

There isn't even a quote from anybody from Lionsgate confirming the deal in the press release like all press releases have when confirming a deal between two companies.

The Lionsgate deal also doesn't
SAPX
TrendTrade2016 TrendTrade2016 23 분 전
TRUMPS POLICY'S MAY STIMULATE THE ECONOMY LONGTERM...BUT SHORT TERM...THE MARKET CRASH HAS TO TAKE PLACE
stink stack stink stack 23 분 전
Cut back on the wine and proof read before posting.
FNMA
Hi_Lo Hi_Lo 25 분 전
https://www.securitieslawyer101.com/2023/shell-hijacker-mark-miller-sentenced-to-one-year-in-prison/

Court documents show that Capitol Capital Corporation received several big chunks of stock in IGEX, then transferred the shares to Tiger Trout Capital LLC, a Puerto Rican entity contro
CNNA IGEX MEDH

최근 히스토리

NASDAQ
TERN
Terns Pharmaceuticals
NYSE
RNR
RenaissanceRe
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유